Dr David Heath is founder and CEO of Cutitronics Ltd, a spin-out company from the University of Strathclyde. David identified a gap in the market for personalised, adaptive skin care which would harness the power of engineering and technology-based innovation, to support consumers in achieving their desired skincare and beauty results.
Cutitronics offers a menu of patented CutiTron™ technology including assessment of personal skin health, a unique method of automated skin stimulation to enhance topical product absorption and precise personalised product dosage. The technology becomes intuitive through adaptive coaching, supporting the consumer to achieve optimum results.
In August 2017 the company announced a strategic partnership with FTSE 100 Company Croda International plc, who recognised CutiTron™ technology as truly innovative and disruptive for the personal care industry. The partnership will support David and the Cutitronics team to progress their ambitious growth and development plans, taking the technology from prototype to market-ready.
